130 related articles for article (PubMed ID: 17721501)
1. Bilateral autoimmune optic neuritis and vitreitis related to CRMP-5-IgG: intravitreal triamcinolone acetonide therapy of four eyes.
Pulido J; Cross SA; Lennon VA; Pulido J; Swanson D; Muench M; Lachance DH
Eye (Lond); 2008 Sep; 22(9):1191-3. PubMed ID: 17721501
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG.
Cross SA; Salomao DR; Parisi JE; Kryzer TJ; Bradley EA; Mines JA; Lam BL; Lennon VA
Ann Neurol; 2003 Jul; 54(1):38-50. PubMed ID: 12838519
[TBL] [Abstract][Full Text] [Related]
3. Collapsin Response-Mediator Protein 5-Associated Retinitis, Vitritis, and Optic Disc Edema.
Cohen DA; Bhatti MT; Pulido JS; Lennon VA; Dubey D; Flanagan EP; Pittock SJ; Klein CJ; Chen JJ
Ophthalmology; 2020 Feb; 127(2):221-229. PubMed ID: 31676123
[TBL] [Abstract][Full Text] [Related]
4. [Paraneoplastic optic neuritis in an unknown small cell lung carcinoma defined by CRMP-5-IgG].
Toribio-García JA; Franco-Benito M; García-Ruiz-de-Morales JM
Arch Soc Esp Oftalmol; 2007 Dec; 82(12):777-80. PubMed ID: 18040924
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.
Jonas JB; Kreissig I; Degenring R
Prog Retin Eye Res; 2005 Sep; 24(5):587-611. PubMed ID: 16005407
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal triamcinolone acetonide for acute radiation papillopathy.
Shields CL; Demirci H; Marr BP; Mashayekhi A; Dai VV; Materin MA; Shields JA
Retina; 2006; 26(5):537-44. PubMed ID: 16770260
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal triamcinolone acetonide for the management of diabetic papillopathy.
Al-Haddad CE; Jurdi FA; Bashshur ZF
Am J Ophthalmol; 2004 Jun; 137(6):1151-3. PubMed ID: 15183815
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal triamcinolone acetonide as adjunctive treatment with systemic therapy for uveitic macular edema.
Habot-Wilner Z; Sallam A; Pacheco PA; Do HH; McCluskey P; Lightman S
Eur J Ophthalmol; 2011; 21 Suppl 6():S56-61. PubMed ID: 23264330
[TBL] [Abstract][Full Text] [Related]
9. CRMP-5-IgG Antibody: role in the bilateral uveitis with swollen disc.
Hernández-Bel L; Puchades-Gimeno F; Fernandez-Diaz A; Mata-Moret L; Beltrán-Catalán E; Hernandez-Garfella ML; Cervera-Taulet E
Rom J Ophthalmol; 2020; 64(2):217-221. PubMed ID: 32685790
[TBL] [Abstract][Full Text] [Related]
10. CRMP-5-IgG in patient with paraneoplastic optic neuritis with lung adenocarcinoma.
Murakami Y; Yoshida S; Yoshikawa H; Yamaji Y; Ikeda Y; Ueno A; Ishibashi T
Eye (Lond); 2007 Jun; 21(6):860-2. PubMed ID: 17277748
[No Abstract] [Full Text] [Related]
11. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
Jonas JB; Kreissig I; Kamppeter B; Degenring RF
Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306
[TBL] [Abstract][Full Text] [Related]
12. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide.
Danis RP; Bingaman DP; Yang Y; Ladd B
Ophthalmology; 1996 Dec; 103(12):2099-104. PubMed ID: 9003344
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
Bae JH; Lee CS; Lee SC
Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
[TBL] [Abstract][Full Text] [Related]
15. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal triamcinolone acetonide: a change in a paradigm.
Jonas JB
Ophthalmic Res; 2006; 38(4):218-45. PubMed ID: 16763379
[TBL] [Abstract][Full Text] [Related]
17. Intraocular pressure after intravitreal injection of triamcinolone acetonide.
Jonas JB; Kreissig I; Degenring R
Br J Ophthalmol; 2003 Jan; 87(1):24-7. PubMed ID: 12488256
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal triamcinolone improves recovery of visual acuity in nonarteritic anterior ischemic optic neuropathy.
Kaderli B; Avci R; Yucel A; Guler K; Gelisken O
J Neuroophthalmol; 2007 Sep; 27(3):164-8. PubMed ID: 17895814
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial.
Chen JJ; Tobin WO; Majed M; Jitprapaikulsan J; Fryer JP; Leavitt JA; Flanagan EP; McKeon A; Pittock SJ
JAMA Ophthalmol; 2018 Apr; 136(4):419-422. PubMed ID: 29470571
[TBL] [Abstract][Full Text] [Related]
20. Onset of an outbreak of Bipolaris hawaiiensis fungal endophthalmitis after intravitreal injections of triamcinolone.
Small KW; Chan CK; Silva-Garcia R; Walsh TJ
Ophthalmology; 2014 Apr; 121(4):952-8. PubMed ID: 24507858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
